Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities (Q39380913)

11 September 2017

1 reference

title

Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities (English)

1 reference

11 September 2017

Möller HJ

1

1 reference

11 September 2017

publication date

1 May 2004

1 reference

11 September 2017

1 reference

11 September 2017

volume

75

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

499-515; quiz 516-7

1 reference

Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment

11 September 2017

cites work

1 reference

12 December 2020

Residual symptoms in depressed patients who respond acutely to fluoxetine.

1 reference

12 December 2020

Prefrontal cortex stimulation as antidepressant treatment: mode of action and clinical effectiveness of rTMS.

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

1 reference

12 December 2020

Monoamine metablites as predictors of anttoepressant response: A critique

1 reference

12 December 2020

Screening and treating depressed patients. A comparison of two controlled citalopram trials across treatment settings: hospitalized patients vs. patients treated by their family doctors. Danish University Antidepressant Group.

1 reference

12 December 2020

Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis

1 reference

12 December 2020

Antidepressants and the brain

1 reference

12 December 2020

Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.

1 reference

12 December 2020

A protocol for the pharmacologic treatment of major depression. A field test of a potential prototype

1 reference

12 December 2020

Serotonin syndrome and drug combinations: focus on MAOI and RIMA

1 reference

12 December 2020

The clinical meaning of refractory depression: a review for the clinician

1 reference

12 December 2020

The combination of olanzapine and fluoxetine in mood disorders

1 reference

12 December 2020

Definition and epidemiology of treatment-resistant depression

1 reference

12 December 2020

Pindolol Augmentation of Treatment-Resistant Depressed Patients

1 reference

12 December 2020

An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression

1 reference

12 December 2020

Duration of REM sleep latency as predictor of effect of antidepressant therapy. A preliminary report

1 reference

12 December 2020

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

1 reference

12 December 2020

Long-term outcome of episodes of major depression. Clinical and public health significance

1 reference

12 December 2020

Treatment of endogenous depressions resistant to tricyclic antidepressants or related drugs by lithium addition. Results of a placebo-controlled double-blind study.

1 reference

12 December 2020

Pretreatment neurotransmitter metabolite levels and response to tricyclic antidepressant drugs

1 reference

12 December 2020

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

1 reference

12 December 2020

Thyroid hormones, the brain, and affective disorders

1 reference

12 December 2020

Should combined pharmaco- and psychotherapy be offered to depressed patients? A qualitative review of randomized clinical trials from the 1990s

1 reference

12 December 2020

Pindolol augmentation of antidepressants: a review and rationale

1 reference

12 December 2020

Monoamine oxidase inhibitors. A review of antidepressant effectiveness

1 reference

12 December 2020

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder

1 reference

12 December 2020

MHPG as a predictor of antidepressant response to imipramine and maprotiline

1 reference

12 December 2020

A preliminary, open study of the combination of fluoxetine and desipramine for rapid treatment of major depression

1 reference

12 December 2020

Treatment of refractory depression with high-dose thyroxine.

1 reference

12 December 2020

Pharmacogenetics: a new diagnostic tool in the management of antidepressive drug therapy

1 reference

12 December 2020

Pharmacogenetics for the individualization of psychiatric treatment

1 reference

12 December 2020

Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness?

1 reference

12 December 2020

Non-response to antidepressants: risk factors and therapeutic possibilities

1 reference

12 December 2020

Chronological milestones to guide drug change. When should clinicians switch antidepressants?

1 reference

12 December 2020

Non-response to antidepressants: risk factors and therapeutic possibilities.

1 reference

12 December 2020

Treatment-resistant depression: definition and treatment approaches

1 reference

12 December 2020

Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial

1 reference

12 December 2020

Initial REM sleep suppression by clomipramine: a prognostic tool for treatment response in patients with a major depressive disorder

1 reference

12 December 2020

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

1 reference

12 December 2020

Monoamine oxidase: A gene polymorphism, tryptophan hydroxylase gene polymorphism and antidepressant response to fluvoxamine in Japanese patients with major depressive disorder

1 reference

12 December 2020

Possible augmentation of antidepressant response by buspirone

1 reference

12 December 2020

Pharmacogenetics of antidepressants: clinical aspects

1 reference

12 December 2020

Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms.

1 reference

12 December 2020

Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects

1 reference

12 December 2020

Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression

1 reference

12 December 2020

Subtypes of Depression Based on Excretion of MHPG and Response to Nortriptyline

1 reference

12 December 2020

Lithium augmentation therapy in tricyclic-resistant depression. A controlled trial using lithium in low and normal doses.

1 reference

12 December 2020

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

1 reference

12 December 2020

Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline

1 reference

12 December 2020

Treating antidepressant nonresponders with augmentation strategies: an overview.

1 reference

12 December 2020

Therapeutic potentials of recently introduced antidepressants. Danish University Antidepressant Group

1 reference

12 December 2020

Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.

1 reference

12 December 2020

Catecholamine Metabolism, Depressive Illness, and Drug Response

1 reference

12 December 2020

When at first you don't succeed: sequential strategies for antidepressant nonresponders

1 reference

12 December 2020

Prediction of therapeutic response in acute treatment with antidepressants. Results of an empirical study involving 159 endogenous depressive inpatients

1 reference

12 December 2020

Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.

1 reference

12 December 2020

Buspirone augmentation of antidepressant therapy

1 reference

12 December 2020

EEG sleep in primary depression. A longitudinal placebo study

1 reference

12 December 2020

Association study of the 5-HT(6) receptor polymorphism (C267T) and symptomatology and antidepressant response in major depressive disorders

1 reference

12 December 2020

Mirtazapine augmentation in the treatment of refractory depression.

1 reference

12 December 2020

Monoamine oxidase inhibitors: a review

1 reference

12 December 2020

The present status of monoamine oxidase inhibitors

1 reference

12 December 2020

Lithium augmentation in treatment-resistant depression: meta-analysis of placebo-controlled studies

1 reference

12 December 2020

Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression

1 reference

12 December 2020

A comparison of comorbid patterns in treatment-resistant unipolar and bipolar depression.

1 reference

12 December 2020

Structure and feasibility of a standardized stepwise drug treatment regimen (SSTR) for depressed inpatients

1 reference

12 December 2020

Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression

1 reference

12 December 2020

Research and methodological issues for evaluating the therapeutic effectiveness of antidepressant drugs

1 reference

12 December 2020

New evidence of serotonin-deficient depressions

1 reference

12 December 2020

Venlafaxine for treatment-resistant unipolar depression

1 reference

12 December 2020

Drug therapy strategies for treatment-resistant depression

1 reference

12 December 2020

Genetic factors and treatment of mood disorders

1 reference

12 December 2020

The prognosis of depression in old age

1 reference

12 December 2020

Consensus guidelines in the treatment of major depressive disorder.

1 reference

12 December 2020

The role of 5-HT(1A) and 5-HT(1B/1D) receptors on the modulation of acute fluoxetine-induced changes in extracellular 5-HT: the mechanism of action of (+/-)pindolol

1 reference

12 December 2020

The short- and long-term efficacy of paroxetine HCl: B. Data from a double-blind crossover study and from a year-long term trial vs. imipramine and placebo

1 reference

12 December 2020

Treatment-resistant depression: clinical significance, concept and management.

1 reference

12 December 2020

The arbitrariness of response definition in clinical trials with antidepressants

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression

1 reference

12 December 2020

Role of pharmacogenomics in individualising treatment with SSRIs

1 reference

12 December 2020

Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.

1 reference

12 December 2020

1 reference

12 December 2020

Indications for therapy using MAO inhibitors

1 reference

12 December 2020

Partial response and nonresponse to antidepressant therapy: current approaches and treatment options.

1 reference

12 December 2020

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

12 December 2020

Collaborative management to achieve treatment guidelines. Impact on depression in primary care

1 reference

12 December 2020

Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.

1 reference

12 December 2020

Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: results of a 2-year observational algorithm study

1 reference

12 December 2020

Depression and MHPG excretion. Response to dextroamphetamine and tricyclic antidepressants

1 reference

12 December 2020

The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleep

1 reference

12 December 2020

Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression

1 reference

12 December 2020

Fluoxetine potentiation by buspirone: three case histories

1 reference

12 December 2020

The pharmacological treatment of delusional depression

1 reference

12 December 2020

1 reference

12 December 2020

Association study of angiotensin I-converting enzyme polymorphism and symptomatology and antidepressant response in major depressive disorders.

1 reference

12 December 2020

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

1 reference

12 December 2020

Epidemiology, demography and definitions

1 reference

12 December 2020

The assessment and treatment of refractory depression.

1 reference

12 December 2020

Therapy resistance to antidepressive drugs: risk factors and treatment possibilities

1 reference

12 December 2020

Biochemical correlates of antidepressant response. Results of a trazodone versus amitriptyline trial

1 reference

12 December 2020

The prophylactic efficacy of fluoxetine in unipolar depression

1 reference

12 December 2020

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

1 reference

12 December 2020

A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression

1 reference

12 December 2020

Predictors of therapeutic effects in amitriptyline treatment--1. Plasma drug levels

1 reference

12 December 2020

Treatment resistant depression: methodological overview and operational criteria

1 reference

12 December 2020

Psychopathologic changes during 20 days of antidepressive or neuroleptic therapy

1 reference

12 December 2020

Rapid down regulation of beta-adrenoceptors by co-administration of desipramine and fluoxetine

1 reference

12 December 2020

Follow-up of depressed women after maintenance treatment

1 reference

12 December 2020

Treatment algorithms in treatment-resistant depression

1 reference

12 December 2020

Augmentation strategies with serotonergic-noradrenergic combinations

1 reference

12 December 2020

"Paradoxical" shortening of REM latency on first recording night in major depressive disorder: clinical and polysomnographic correlates

1 reference

12 December 2020

Depression vulnerability and 5-hydroxytryptophan prophylaxis

1 reference

12 December 2020

A rational approach to the non-responding depressed patient

1 reference

12 December 2020

Definition and differential diagnosis of treatment-resistant depression

1 reference

12 December 2020

10.1007/S00115-004-1728-1

Identifiers

DOI

1 reference

11 September 2017

1 reference